Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Mototsugu Nagao

Lecturer

Nippon Medical School

Japan

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Japan Professors in Biochemistry Biochemistry professors in Japan

About

Dr. Mototsugu Nagao is a Lecturer at Nippon Medical School in Japan. His research focuses on various aspects of diabetes, including the pathophysiology of type 2 diabetes, biomarkers for tumor-related hypoglycemia, and lipid profiles in thyroid disorders. He has published several recent articles addressing the physiological mechanisms in pancreatic islets and the impact of treatment strategies in diabetes management.

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (3)

Itaru Kato

Kyoto University Hospital

JAPAN

View details

Katsutsugu Umeda

講師 / Senior Lecturer/ Junior Associate Professor

Kyoto University

JAPAN

View details

Lena Eliasson

Lund University

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mototsugu Nagao

Research Interests

Make your next move.

Explore related searches

About

Articles (18)

Pediatric Case of Non‐Islet Cell Tumor Hypoglycemia Driven by Hepatoblastoma: The Diagnostic Approach and Impact of Chemotherapy on Big IGF‐II

MicroRNA‐Driven Regulation of β‐Cell Function in Type 2 Diabetes: Molecular Mechanisms, Network Insights, and Translational Perspectives

Preoperative eGFR, age, and sex predict early postoperative renal changes in acromegaly

Exploring the link between atherosclerosis indicators and QT interval in type 2 diabetes: a retrospective cross-sectional analysis

Potential Utility of Circulating MicroRNA-483 as a Biomarker for IGF-II–Associated Non–Islet Cell Tumor Hypoglycemia

Impact of Graves’ hyperthyroidism treatment on lipid profiles and cholesterol dynamics: a prospective observational study

Real‐Time Detection of Somatostatin Release From Single Pancreatic Islets Reveals δ‐Cell Dysfunction in Type 2 Diabetes

Unraveling the pathophysiology of type 2 diabetes with a new selectively bred animal model, the Oikawa-Nagao mouse

Secretory granule exocytosis and its amplification by cAMP in pancreatic β-cells

A case of pheochromocytoma associated with liver abscess and intestinal pseudo-obstruction

Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study

Multiple daily insulin injections ameliorate QT interval by lowering blood glucose levels in patients with type 2 diabetes

Different pathogenesis of glucose intolerance in two subtypes of primary aldosteronism: Aldosterone‐producing adenoma and idiopathic hyperaldosteronism

Insulin and heparin challenge tests are useful for choosing an optimal insulin regimen in a case of subcutaneous insulin resistance

Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice.

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells.

Sitagliptin Improves Plasma Apolipoprotein Profile in Type 2 Diabetes: A Randomized Clinical Trial of Sitagliptin Effect on Lipid and Glucose Metabolism (SLIM) Study.

Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA

Collaborators (3)

Itaru Kato

Katsutsugu Umeda

Lena Eliasson

Make your next move.